OBJECTIVE: To determine physicians' level of awareness and knowledge of Lyme disease (LD) in a low-prevalence area and whether physicians' practices align with current guidelines for treatment of LD. DESIGN: A 23-item questionnaire assessing demographic characteristics, general knowledge about LD, laboratory testing for LD, and responses to 3 clinical scenarios. SETTING: British Columbia (BC). PARTICIPANTS: Pediatricians, FPs, and internal medicine specialists who were licensed to practise in BC. MAIN OUTCOME MEASURES: Knowledge of signs and symptoms of LD, beliefs about risk of LD, attitudes toward LD in patients in their practices, and application of accepted practice guidelines for the treatment of LD in clinical scenarios. RESULTS: Overall, 80.6% of respondents were FPs. Average knowledge score was 72.5% for FPs and 75.0% for other specialists. Most respondents (75.6% of FPs and 71.8% of other specialists) underestimated the occurrence of erythema migrans (EM), and only 26.1% and 28.3%, respectively, knew that EM alone was diagnostic for LD. A total of 30.5% of FPs and 12.1% of other specialists reported having treated a patient for the disease despite not believing that the patient had LD. Of all the respondents, 62.1% knew that LD was a reportable disease in BC. Respondents' reports of risk of LD in their areas were appropriately associated with actual risk based on ecological niche. CONCLUSION: Physicians are knowledgeable about the clinical signs and symptoms of LD and aware of the risk of the disease despite being in a low-endemic area. Physicians in BC are comfortable with treating patients empirically for LD. Education is needed to inform physicians that EM is diagnostic and no laboratory testing is indicated before treatment. Raising awareness among physicians that LD is reportable might improve reporting of future cases.
OBJECTIVE: To determine physicians' level of awareness and knowledge of Lyme disease (LD) in a low-prevalence area and whether physicians' practices align with current guidelines for treatment of LD. DESIGN: A 23-item questionnaire assessing demographic characteristics, general knowledge about LD, laboratory testing for LD, and responses to 3 clinical scenarios. SETTING:British Columbia (BC). PARTICIPANTS: Pediatricians, FPs, and internal medicine specialists who were licensed to practise in BC. MAIN OUTCOME MEASURES: Knowledge of signs and symptoms of LD, beliefs about risk of LD, attitudes toward LD in patients in their practices, and application of accepted practice guidelines for the treatment of LD in clinical scenarios. RESULTS: Overall, 80.6% of respondents were FPs. Average knowledge score was 72.5% for FPs and 75.0% for other specialists. Most respondents (75.6% of FPs and 71.8% of other specialists) underestimated the occurrence of erythema migrans (EM), and only 26.1% and 28.3%, respectively, knew that EM alone was diagnostic for LD. A total of 30.5% of FPs and 12.1% of other specialists reported having treated a patient for the disease despite not believing that the patient had LD. Of all the respondents, 62.1% knew that LD was a reportable disease in BC. Respondents' reports of risk of LD in their areas were appropriately associated with actual risk based on ecological niche. CONCLUSION: Physicians are knowledgeable about the clinical signs and symptoms of LD and aware of the risk of the disease despite being in a low-endemic area. Physicians in BC are comfortable with treating patients empirically for LD. Education is needed to inform physicians that EM is diagnostic and no laboratory testing is indicated before treatment. Raising awareness among physicians that LD is reportable might improve reporting of future cases.
Authors: Gary P Wormser; Raymond J Dattwyler; Eugene D Shapiro; John J Halperin; Allen C Steere; Mark S Klempner; Peter J Krause; Johan S Bakken; Franc Strle; Gerold Stanek; Linda Bockenstedt; Durland Fish; J Stephen Dumler; Robert B Nadelman Journal: Clin Infect Dis Date: 2006-10-02 Impact factor: 9.079
Authors: Muhammad G Morshed; John D Scott; Keerthi Fernando; Lorenza Beati; Daniel F Mazerolle; Glenna Geddes; Lance A Durden Journal: J Parasitol Date: 2005-08 Impact factor: 1.276
Authors: Robert L Bratton; John W Whiteside; Michael J Hovan; Richard L Engle; Frederick D Edwards Journal: Mayo Clin Proc Date: 2008-05 Impact factor: 7.616
Authors: S Esposito; E Baggi; A Villani; S Norbedo; G Pellegrini; E Bozzola; E Palumbo; S Bosis; G Nigro; S Garazzino; N Principi Journal: Eur J Clin Microbiol Infect Dis Date: 2012-10-30 Impact factor: 3.267
Authors: Cécile Ferrouillet; François Milord; Louise Lambert; Anne Vibien; André Ravel Journal: Can J Infect Dis Med Microbiol Date: 2015 May-Jun Impact factor: 2.471